BioCentury
ARTICLE | Company News

GEn1E gains option to p38 MAPK inhibitor

October 19, 2018 5:34 PM UTC

GEn1E Lifesciences Inc. (Palo Alto, Calif.) gained an exclusive option to license a patent application from the University of Maryland Baltimore (Baltimore, Md.) covering methods and use of p38 mitoge...